SCR-LIP-000161 · Claim · machine-readable JSON →
In an 8-week RCT of 70 females with lipedema and obesity, a 1200 kcal/d low-carbohydrate diet produced greater fat mass loss (-7.0 vs -5.1 kg) and significant within-group reductions in hsCRP, TNF-α and MIP-1β versus a low-fat diet, but no between-group differences in cytokines or fibrosis markers were found, and changes in pain were not associated with changes in inflammatory markers or ketosis.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- high (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Changes in Cytokines and Fibrotic Growth Factors after Low-Carbohydrate or Low-Fat Low-Energy Diets in Females with Lipedema — Lundanes et al. (2025) ✓ verified — refining · rct · 2025 · reading confidence: high
“Mudanças em citocinas e marcadores associados à fibrose não diferiram entre dietas LCD e low-fat hipocalóricas em mulheres com lipedema, apesar do perfil benéfico observado no grupo LCD”
RCT directly comparing low-carbohydrate vs low-fat diet in lipedema; LCD showed greater fat loss and favorable within-group inflammatory profile but no between-group superiority, and pain reduction was not mediated by systemic inflammation,
Context (PECO)
Answers these questions
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created